Indianapolis, IN, United States of America

Lien H Koztecki

USPTO Granted Patents = 2 


Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lien H Koztecki: Innovator in Pharmaceutical Patents

Introduction

Lien H Koztecki is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Koztecki has focused on developing novel crystalline forms and polymorphs that have important applications in medicine.

Latest Patents

Koztecki's latest patents include groundbreaking work on crystalline forms of oxymorphone hydrochloride. This invention is directed towards enhancing the stability and efficacy of this important pharmaceutical compound. Additionally, he has developed polymorphs of the succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile. This patent outlines methods for preparing these polymorphs and their use in treating various diseases, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Koztecki has worked with reputable companies, including Noramco GmbH. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate and create valuable patents that contribute to healthcare advancements.

Collaborations

Koztecki has collaborated with several professionals in his field, including Karen Sue Gushurst and Leonard J Chyall. These collaborations have likely enriched his work and led to the development of his significant inventions.

Conclusion

Lien H Koztecki is a distinguished inventor whose work in pharmaceutical patents has made a meaningful impact on the industry. His innovative approaches to crystalline forms and polymorphs demonstrate his dedication to improving medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…